[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368006-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368006-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cancer-incidence-stage-at-diagnosis-and-trends-across-the-navajo-nation-2014-2018","Cancer incidence, stage at diagnosis, and trends across the Navajo Nation, 2014-2018","","Study findings describe cancer incidence from 2014–2018, long-term trends from 1998–2018, and stage at diagnosis across the Navajo Nation, addressing known cancer disparities among American Indian/Alaska Native peoples. Population-based registry cases from Arizona, New Mexico, and Utah counties were linked to Indian Health Services patient registrations. Incidence and stage comparisons used Navajo versus non-Hispanic White groups, while Joinpoint regression evaluated trends. Results show higher Navajo incidence for selected cancers and a late-stage pattern for cervical and colorectal disease, with an overall decrease from 2010 to 2018.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cancer-incidence-stage-at-diagnosis-and-trends-across-the-navajo-nation-2014-2018/368006/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cancer-incidence-stage-at-diagnosis-and-trends-across-the-navajo-nation-2014-2018/368006.png","ImageObject",300,407,{"name":42,"@type":43},"RuangKosong","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does the study examine for the Navajo Nation from 2014–2018?","Question",{"text":63,"@type":64},"It examines cancer incidence and the stage at diagnosis among Navajo people in six counties covering the Navajo Nation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were cancer trends from 1998–2018 analyzed?",{"text":68,"@type":64},"Trends from 1998 through 2018 were analyzed using Joinpoint regression.",{"name":70,"@type":61,"acceptedAnswer":71},"Which cancer patterns differed most between Navajo people and non-Hispanic White people?",{"text":72,"@type":64},"Navajo people had higher incidence for several cancers (e.g., gallbladder, stomach, kidney, myeloma, and liver) and lower incidence for others (e.g., lung, female breast, leukemia, prostate, pancreas, and non-Hodgkin lymphoma).","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368006,1790481801,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":113,"preview_page_count":33,"preview_urls":146},962090883219,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","DOI: 10. 1002/cncr.70202  \nORIGINAL ARTICLE  \nCancer incidence, stage at diagnosis, and trends across the Navajo Nation, 2014—2018  \nDel Yazzie MPH1  | Dornell Pete PhD, MPH2 | Curtis Briscoe BS3 | Melissa A. Jim MPH4 | Angela Meisner MPH5 | Charles Wiggins PhD5 |  \nDana Doyle MPH6 | Georgia Yee BSW, ODS-C6 | Carol Goldtooth MPH7  | Priscilla R. Sanderson PhD7 | Chesleigh Nicole Keene PhD8 | Melinda Smith PhD7 | Hannah Sehn MMSc9 | Shawnell Damon MPH, MSc10 |  \nChelsea L. Kettering DrPH, MPH11  | Marc Emerson PhD 12  |  \nCaleigh Curley MPH13 | Jennifer Bea PhD13 | Sheldwin Yazzie PhD, MPH, MS14 | Natalie Joe PhD, MPH15  | Jennifer Doherty PhD 16 |  \nHendrik Dirk de Heer PhD, MPH7 | On behalf of the Navajo Cancer Workgroup  \nCorrespondence  \nDel Yazzie, Navajo Department of Health, P.O. Box 1390, Window Rock, AZ, USA.  \nEmail: [dely@navajo-nsn.gov](dely@navajo-nsn.gov)  \nFunding information  \nNational Cancer Institute, Grant/Award Numbers: HHSN2612018000014I, K00CA253685, U54CA143924, U54CA143925; Indian Health Service, Grant/ Award Number: U1B1IHS0011-12-00; American Cancer Society, Grant/Award Number: Cancer Health Research Centers  \nAbstract  \nBackground: American Indian/Alaska Native (AI/AN) people in the United States experience cancer disparities, but little is known about cancer patterns specific to each Tribal Nation. This study describes cancer incidence (2014–2018), trends (1998–2018), and stage of diagnosis across the Navajo Nation, one of the largest sovereign tribal nations worldwide.  \nMethods: Cases from six Arizona, New Mexico, and Utah counties covering most of the Navajo Nation were identified by population-based cancer registries and linked with Indian Health Services patient registrations. Cancer incidence and stage at diagnosis were compared between Navajo and non-Hispanic White persons in the same counties. Trends from 1998 through 2018 were analyzed using Joinpoint regression.  \nResults: Navajo people had significantly higher incidence than non-Hispanic White people of gallbladder (incidence rate ratio [RR] = 6. 25), stomach (RR = 3. 19), kidney (RR = 1.89), myeloma (RR = 1.80), and liver cancers (RR = 1. 79) and a lower incidence of cancers of the lung (RR = 0. 16), female breast (RR = 0.49), leukemia (RR = 0.49), prostate (RR = 0. 62), pancreas (RR = 0. 79), and non-Hodgkin lymphoma (RR = 0. 79). Diagnostic stage was not different for breast, cervical, and colorectal cancers, but two thirds of patients with cervical and colorectal cancer were diagnosed in later/unknown stages. Although all-site cancer rates did not change  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.  \n© 2025 The Author(s). Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society.  \nCancer. 2025;e70202.  \n[https://doi.org/10.1002/cncr.70202](https://doi.org/10.1002/cncr.70202)  \nwi[leyonlinelibrary.com/journal/cncr](leyonlinelibrary.com/journal/cncr)  \n1 of 12  \nsignificantly from 1998 through 2018 among Navajo people, a significant decrease was found from 2010 through 2018 (–2. 1% annual percentage change, p \u003C .01). Conclusions: Navajo people experience a higher incidence of kidney, stomach, liver, myeloma, and gallbladder cancers and a lower incidence of cancers of the breast, prostate, lung, non-Hodgkin lymphoma, and leukemia. Tailored and targeted prevention efforts may help reduce cancer disparities in the Navajo Nation.  \nPlain Language Summary  \n􀀐 This study summarized cancer rates during 2014 through 2018 among Navajo people in six counties covering the Navajo Nation, one of the largest sovereign Tribal Nations worldwide.  \n􀀐 Compared to White people in the same area, Navajo people had higher rates of liver, kidney, myeloma, gallbladder, and stomach cancers, and lower rate","cbCaioQoaQXFEtCW","https://ap.wps.com/l/cbCaioQoaQXFEtCW","pdf",1081298,12,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n# Plain Language Summary\n# Keywords","[{\"question\":\"What does the study examine for the Navajo Nation from 2014–2018?\",\"answer\":\"It examines cancer incidence and the stage at diagnosis among Navajo people in six counties covering the Navajo Nation.\"},{\"question\":\"How were cancer trends from 1998–2018 analyzed?\",\"answer\":\"Trends from 1998 through 2018 were analyzed using Joinpoint regression.\"},{\"question\":\"Which cancer patterns differed most between Navajo people and non-Hispanic White people?\",\"answer\":\"Navajo people had higher incidence for several cancers (e.g., gallbladder, stomach, kidney, myeloma, and liver) and lower incidence for others (e.g., lung, female breast, leukemia, prostate, pancreas, and non-Hodgkin lymphoma).\"}]","Cancer incidence, stage at diagnosis, and trends across the Navajo Nation, 2014-2018 | PDF",1790174300,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2bcf16ce3e6103c303e95f8032b484b7.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/34c0a79a2a9432bac4f918b1546a9b2b.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f9e39dbf77cca98917ad87d38fcbacf7.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cecb77ff33b41a60d3a7ea821bc016db.webp",980,1287]